Mirae Asset Global ETFs Holdings’s BioNTech BNTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.54M	Buy	38,015 +10,480	+38%	+$986K	﹤0.01%	997
2026 Q1	$2.45M	Buy	27,535 +1,321	+5%	+$136K	﹤0.01%	1089
2025 Q4	$2.5M	Buy	26,214 +8,468	+48%	+$853K	﹤0.01%	1056
2025 Q3	$1.75M	Sell	17,746 -498	-3%	-$53.2K	﹤0.01%	1202
2025 Q2	$1.94M	Sell	18,244 -10,161	-36%	-$1.03M	﹤0.01%	1113
2025 Q1	$2.59M	Sell	28,405 -2,010	-7%	-$225K	0.01%	999
2024 Q4	$3.47M	Sell	30,415 -5,837	-16%	-$666K	0.01%	880
2024 Q3	$4.31M	Sell	36,252 -8,019	-18%	-$737K	0.01%	816
2024 Q2	$3.56M	Buy	+44,271	New	+$4.05M	0.01%	854

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Mirae Asset Global ETFs Holdings's BNTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its BioNTech (BNTX) stake by 38% in Q2 2026, buying an estimated $986K and bringing the position to 38,015 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Mirae Asset Global ETFs Holdings first reported a position in BNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.31M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 38,015 shares of BioNTech worth $3.54M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 10,480 BioNTech shares in Q2 2026, an estimated $986K.
BioNTech made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #997 holding.
Mirae Asset Global ETFs Holdings first reported a position in BioNTech in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's BioNTech position peaked at $4.31M in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.